Comparison in Efficacy and Safety Between Interferon Alfacon-1 Alone and Concomitant Dosing With Ribavirin for the Treatment of Hepatitis C
NCT00239252 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL
Last updated 2014-08-26
Summary
Efficacy and safety is compared between interferon alfacon-1 alone and concomitant dosing of interferon alfacon-1 and ribavirin in hepatitis C patients.
Conditions
- Hepatitis C
Interventions
- DRUG
-
Interferon alfacon-1
Sponsors & Collaborators
-
Schering-Plough
collaborator INDUSTRY -
Astellas Pharma Inc
lead INDUSTRY
Principal Investigators
-
Clinical Development III · Astellas Pharm. Inc.
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- Japan
More Related Trials
-
A Multicenter Phase 3 Study of Interferon-beta-1a for the Treatment of Chronic Hepatitis C in Asian Subjects
NCT00249860 ·Status: COMPLETED ·Phase: PHASE3
-
Exploration of Chronic Hepatitis C Infection Receiving 24-week Interferon-α With Ribavirin Treatments
NCT01178749 ·Status: UNKNOWN
-
Combination Drug Therapy for Patients With Hepatitis C
NCT00001729 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of MP-424, Peginterferon Alfa-2b, and Ribavirin in Patients With Chronic Hepatitis C Who Relapsed After Previous Interferon Based Therapy
NCT00780910 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy Study of New Therapeutic Schedules in Naive Hepatitis C Virus (HCV) Patients Infected With Genotype 3 (HCV-3)
NCT01121705 ·Status: COMPLETED ·Phase: PHASE3
-
Pilot Study of Patients Chronic Hepatitis C in Co-infected HIV Patients Relapsers After Previous Therapies
NCT00530972 ·Status: COMPLETED ·Phase: PHASE4
-
Peginterferon Plus Ribavirin for Hepatitis C Patients Concomitant With Hepatocellular Carcinoma
NCT00834860 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy and Safety of MP-424, Interferon Beta (IFN Beta), and Ribavirin(RBV) in Treatment-Naïve or Having Received Interferon Based Therapy With Chronic Hepatitis C (CHC)
NCT01753570 ·Status: COMPLETED ·Phase: PHASE3
-
Daily-Dose Consensus Interferon and Ribavirin: Efficacy of Combined Therapy
NCT00086541 ·Status: COMPLETED ·Phase: PHASE3
-
Peginterferon Alfa-2a and Ribavirin for Genotype 2 Chronic Hepatitis C: Duration and Ribavirin Dose Stratified by RVR
NCT00532701 ·Status: COMPLETED ·Phase: PHASE4
-
PEG-IFN Plus Ribavirin Combination Therapy for Older Patients
NCT00956982 ·Status: UNKNOWN ·Phase: NA
-
Randomized Trial of 24 or 48 Weeks of Peginterferon Alfa-2a Plus Ribavirin for HCV Genotype 1-infected Patients
NCT00495131 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of PEG-Intron and Two Different Doses of Ribavirin for the Treatment of Chronic Hepatitis C In Treatment Naïve Subjects
NCT00299936 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of MP-424, Peginterferon Alfa-2a (PEG-IFN Alfa-2a), and Ribavirin(RBV) in Treatment-Naïve or Relapsed Hepatitis C
NCT01753557 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of Pegylated Interferon Lambda Versus Pegylated Interferon Alfa, Plus Ribavirin in Subjects With Hepatitis C
NCT01447394 ·Status: WITHDRAWN ·Phase: PHASE3
-
Micro RNA-122 and the Clinical Course of Patients With Chronic Hepatitis C
NCT00980161 ·Status: UNKNOWN
-
A Study to Evaluate the Efficacy and Safety of Three Experimental Drugs Compared With Telaprevir (a Licensed Product) in People With Hepatitis C Virus Infection Who Have Not Had Treatment Before
NCT01854697 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Peginterferon Alfa-2a in Combination With Ribavirin in Chronic Hepatitis C (CHC) Patients With Compensated Liver Cirrhosis (LC)
NCT00304551 ·Status: COMPLETED ·Phase: PHASE3
-
CIFN and IFN γ-1b With or Without Ribavirin for Treatment of Chronic Hepatitis C (Nonresponders)
NCT00084279 ·Status: COMPLETED ·Phase: PHASE2
-
Ribavirin Dose Optimization for the Treatment of Hepatitis C
NCT01289496 ·Status: COMPLETED ·Phase: PHASE2
-
Japanese Pegylated Interferon (PegIFN) Alfa-2b/Ribavirin (RBV) Combination Trial
NCT01579474 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin in Treatment-Naive Hepatitis C Patients
NCT00637923 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 3, Comparative Study of Asunaprevir and Daclatasvir Combination Therapy Versus Telaprevir Therapy in Japanese HCV Subjects
NCT01718145 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Albuferon and Ribavirin in Interferon Naive Subjects With Chronic Hepatitis C Genotype 1
NCT00115908 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of PegIntron Plus Rebetol in Patients With Chronic Hepatitis C in Japan, Excluding (1) Subjects With HCV Genotype 1 and High Viral Load, and (2) Interferon-naïve Subjects With Low Viral Load (Study P04841)(COMPLETED)
NCT00724230 ·Status: COMPLETED